March 2015 Archives

Crude oil prices dropped as nuclear negotiations with Iran extended beyond the original deadline. The markets slumped to close sharply lower the Dow collapsing 200 points to 17,776.  Nasdaq plunged 46 points to 4,900.

On the upside

Craig-Hallum initiated coverage of Cambrex (NYSE: CBM) with a Buy rating and a $50 price target.

MLV & Co. upgraded Coronado Biosciences (Nasdaq: CNDO) from a Hold rating to a Buy rating.

Piper Jaffray lifted its price target on J.C. Penney (NYSE: JCP) from $13 to $14.

On the downside

Shares of OvaScience (Nasdaq: OVAS) extended its losses.

SAIC (NYSE: SAIC) reported higher fourth quarter earnings and revenue that topped analyst estimates but the stock price dropped.
 
Concerns of a coal glut weighed down shares of Peabody Energy (NYSE: BTU).

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 tumbled 18 points to 2067. Bitcoin slipped $2 to $243.

Markets fall as crude oil retreats

|
Falling crude oil prices weighed the markets down during the midday with the Dow dropping 86 points to 17,889.  Nasdaq fell 18 points to 4,929.

On the upside

RADA Electronic Industries (Nasdaq: RADA) entered a strategic agreement with DRS Technologies to introduce RADA's tactical active electronically scanned array radar technology to North America.

E-Commerce China Dangdang (Nasdaq: DANG) reported sharply higher fourth quarter earnings that topped analyst estimates as revenue climbed.

Fourth quarter earnings climbed for Movado Group (NYSE: MOV) to surpass analyst expectations by a wide margin.

On the downside

Raptor Pharmaceutical (Nasdaq: RPTP) announced a public offering of $75 million worth of common stock.

Celladon (Nasdaq: CLDN) widened losses for the fourth quarter.
 
Shares of Ohr Pharmaceutical (Nasdaq: OHRP) continued falling.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 fell 7 points to 2078. Bitcoin slipped $2 to $242.
The markets opened lower with the Dow tumbling 79 points to 17,896 as the deadline to reach a nuclear deal with Iran loomed.  Nasdaq lost 17 points to 4,929.

On the upside

Piper Jaffray upgraded Horizon Pharma (Nasdaq: HZNP) from a Neutral rating to an Overweight rating.

The U.S. Patent and Trademark Office issued a patent to Great Basin Scientific (Nasdaq: GBSN) for the company's method of isothermal helicase-dependent amplification using blocked primers.

Charter Communications (Nasdaq: CHTR) will acquire rival Bright House Networks in a cash and stock deal valued at approximately $10.4 billion.

On the downside

Synta Pharmaceuticals (Nasdaq: SNTA) priced its public offering of 22 million common shares at the discounted price of $1.75.

Teck Resources (NYSE: TCK) denied that it engaged in merger discussions with Antofagasta.
 
Vaalco Energy (NYSE: EGY) will plug and abandon the post-salt Kindele-1 well offshore Angola.

In the broad market, declining issues outpaced advancers by a margin of nearly 4 to 1 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 lost 8 points to 2077. Bitcoin slipped $3 to $242.
Corporate consolidations sparked a rally that sent the markets soaring to a sharply higher close with the Dow rocketing 263 points to 17,976.  Nasdaq leaped 56 points to 4,947.

On the upside

Bargain hunters lifted shares of Genetic Technologies (Nasdaq: GENE).

Ford (NYSE: F) introduced the revived Lincoln Continental Concept using patented technology from Research Frontiers (Nasdaq: REFR) for an SPD-SmartGlass electronically tinting sunroof.

Fortune Brands Home & Security (NYSE: FBHS) offered a premium of approximately $600 million in cash to buy Norcraft (NYSE: NCFT).

On the downside

H.C. Wainwright analyst Andrew S. Fein said that data from a small study that was released by OvaScience (Nasdaq: OVAS) last week was promising but that it was too early to determine the viability of the fertility treatment Augment.

RBC Capital Markets downgraded Oi SA (NYSE: OIBR) from a Sector Perform rating to an Underperform rating.
 
Shares of 500.com (NYSE: WBAI) extended its losses.

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 soared 25 points to 2086. Bitcoin added $6 to $246.
Pending home sales surged more than expected to send the markets soaring during the midday with the Dow leaping 270 points to 17,982.  Nasdaq jumped 50 points to 4,941.

On the upside

Fujifilm Holdings will buy Cellular Dynamics International (Nasdaq: ICEL) for a premium of approximately $307 million in cash.

ChinaNet Online Holdings (Nasdaq: CNET) entered a service partner agreement with Baidu (Nasdaq: BIDU).

Barclays upgraded Analog Devices (Nasdaq: ADI) from an Equal Weight rating to an Overweight rating.

On the downside

Investors locked in profits on World Wrestling Entertainment (NYSE: WWE) after the entertainment company reported record attendance at Levi's Stadium and record company revenue for a live event for WrestleMania 31 on Sunday.

The Food and Drug Administration issued a Complete Response Letter to Adamis Pharmaceuticals (Nasdaq: ADMP) for its Pre-filled Single Dose Epinephrine Syringe.
 
Wunderlich Securities downgraded Breitburn Energy Partners (Nasdaq: BBEP) from a Hold rating to a Sell rating.

In the broad market, advancing issues outpaced decliners by a margin of 5 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 soared 24 points to 2085. Bitcoin rose $3 to $243. 
A flurry of pharmaceutical acquisitions sent the markets soaring to a sharply higher open with the Dow jumping 257 points to 17,970.  Nasdaq surged 45 points to 4,936.

On the upside

United Health Group will acquire pharmacy benefits manager Catamaran (Nasdaq: CTRX) in a deal valued at approximately $12.8 billion.

Auspex Pharmaceuticals (Nasdaq: ASPX) agreed to be acquired by Teva Pharmaceuticals (NYSE: TEVA) in a transaction valued at approximately $3.5 billion.

Horizon (Nasdaq: HZNP) will pay a premium of approximately $1.1 billion in cash to buy Hyperion Therapeutics (Nasdaq: HPTX).

On the downside

BioDelivery Sciences International (Nasdaq: BDSI) reported disappointing results from a Phase 3 study of Clonidine Topical Gel to treat painful diabetic neuropathy.

Abbott Laboratories will sell 35 million common shares of Mylan (Nasdaq: MYL) that it holds.
 
Morgan Stanley downgraded Altera (Nasdaq: ALTR) from an Overweight rating to an Equal Weight rating.

In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 surged 21 points to 2082. Bitcoin added $2 to $242.

Higher close on M&A news

|
Merger and acquisition news lifted the markets to a higher close with the Dow rising 34 points to 17,712.  Nasdaq climbed 27 points to 4,891.

On the upside

The Wall Street Journal reported that Intel (Nasdaq: INTC) engaged in discussions to acquire Altera (Nasdaq: ALTR).

ChinaCache International (Nasdaq: CCIH) swung to a profit for the fourth quarter.

Bargain hunters continued to snap up shares of Advanced Micro Devices (Nasdaq: AMD).

On the downside

Falling crude oil prices weighed down shares of Energy XXI (Nasdaq: EXXI) and Magnum Hunter Resources (NYSE: MHR).

OvaScience (Nasdaq: OVAS) discussed pregnancy rates of women who received its AUGMENT treatment in a conference call with analysts.
 
MOL Global (Nasdaq: MOLG) fell to a loss for the fourth quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 rose 4 points to 2061. Bitcoin added $1 to $247.
The markets traded near the flatline during the midday with the Dow slipping a point to 17,676 as economic growth in the fourth quarter slowed.  Nasdaq rose 11 points to 4,874.

On the upside

Shares of Kraft Foods (Nasdaq: KRFT) continued climbing.

BlackBerry (Nasdaq: BBRY) reported an unexpected profit for the fourth quarter.

Fourth quarter earnings rose for Oxford Industries (NYSE: OXM) to beat analyst expectations.

On the downside

Falling steel consumption in China weighed down shares of Gerdau (NYSE: GGB).

Applied DNA Sciences (Nasdaq: APDN) priced its public offering of 3.82 million common shares at the discounted price of $3.00 per share.
 
Shares of SandRidge Energy (NYSE: SD) fell as crude oil prices retreated.

In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by 10 to 9 on Nasdaq. The broader S&P 500 edged up a fraction to 2057. Bitcoin added $1 to $247.
The nation's economic growth expanded at a modest 2.2% in the fourth quarter which allayed fears of an interest rate increase. The markets opened higher with the Dow rising 12 points to 17,690. Nasdaq gained 22 points to 4,885.

On the upside

Olin (NYSE: OLN) will acquire Dow Chemical's (NYSE: DOW) chlor-alkali and downstream derivatives businesses in a cash and stock transaction valued at approximately $5 billion.

LiveDeal (Nasdaq: LIVE) products will now be available on Amazon.

Carnival (NYSE: CCL) reversed year ago losses to post a stronger than expected profit for the first quarter.

On the downside

Ohr Pharmaceutical (Nasdaq: OHRP) reported disappointing results from a Phase II study of its eye drop solution OHR-102.

Quiksilver (NYSE: ZQK) chief executive Andy Mooney departed the company and will be replaced by Pierre Agnes.
 
Shares of Peabody Energy (NYSE: BTU) continued to fall.

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 slipped 4 points to 2056. Bitcoin added $1 to $246.
Concerns about escalating violence in the Middle East weighed the markets down to a lower close with the Dow losing 40 points to 17,678. Nasdaq fell 13 points to 4,863.

On the upside

A district court granted On Track Innovations' (Nasdaq: OTIV) motion for a summary judgment that T-Mobile infringed on On Track's patent.

GenFit reported disappointing data from a clinical trial which lifted shares of competitor Intercept Pharmaceuticals (Nasdaq: ICPT).

Bloomberg reported that Synergy Pharmaceuticals (Nasdaq: SGYP) was exploring a possible sale of the company.

On the downside

Enova International (NYSE: ENVA) affirmed its guidance for the full year but the stock price fell.

Shares of World Acceptance (Nasdaq: WRLD) extended its losses.
 
Possible changes to the process that royalties are collected from coal mined on federal land weighed down shares of Peabody Energy (NYSE: BTU).

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 slipped 4 points to 2056. Bitcoin added $1 to $246.
The markets recovered its losses during the midday to trade near the flatline with the Dow slipping 8 points to 17,710 as crude oil prices climbed. Nasdaq lost 6 points to 4,869.

On the upside

SolarEdge Technologies (Nasdaq: SEDG) surged in its market debut.

Diplomat Pharmacy (NYSE: DPLO) priced its follow-on public offering of approximately 8.54 million common shares at $29.00 per share.

Procter & Gamble partnered with WaferGen Bio-systems (Nasdaq: WGBS) to use WaferGen's SmartChip MyDesign(TM) System to conduct gene expression and other studies.

On the downside

Winnebago Industries (NYSE: WGO) disappointed with lower second quarter earnings that fell short of analyst expectations.

Sagent Pharmaceuticals (Nasdaq: SGNT) founder and chief executive Jeffrey Yordon will retire.
 
Standard & Poor's downgraded its outlook on Petrobras (NYSE: PBR) from Stable to Negative.

In the broad market, declining issues outpaced advancers by a margin of nearly 3 to 2 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 held steady at 2061. Bitcoin added $4 to $249.
Despite a drop in jobless claims, the markets opened sharply lower with the Dow plunging 121 points to 17,596 as Saudi Arabia launched airstrikes in Yemen. Nasdaq plummeted 49 points to 4,827.

On the upside

Conatus Pharmaceuticals (Nasdaq: CNAT) reported upbeat results from a Phase 2 clinical trial of emricasan in patients with nonalcoholic fatty liver disease.

Five Below (Nasdaq: FIVE) reported higher fourth quarter earnings and revenue that beat analyst expectations.

Fourth quarter earnings and revenue rose for Red Hat (NYSE: RHT) to surpass analyst expectations.

On the downside

SanDisk (Nasdaq: SNDK) blamed disappointing sales for lowering its first quarter revenue guidance.

Sucampo Pharmaceuticals (Nasdaq: SCMP) priced its public offering of 4 million common shares at the discounted price of $14 per share.
 
Novavax (Nasdaq: NVAX) priced its public offering of more than 24.13 million common shares at the discounted price of $7.25 per share.

In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 lost 13 points to 2047. Bitcoin rose $6 to $251.
Durable goods orders unexpectedly dropped last month to send the markets tumbling to a sharply lower close with the Dow collapsing 292 points to 17,718. Nasdaq crashed 118 points to 4,876.

On the upside

An article yesterday incorrectly wrote that Hunan Xindaxin offered $60 billion to acquire Origin Agritech (Nasdaq: SEED). Hunan Xindaxin had offered $60 million last year to buy the agricultural biotechnology company.

EXCO Resources (Nasdaq: XCO) will present at the 43rd Annual Scotia Howard Weil Energy Conference tomorrow in New Orleans.

Rising crude oil prices lifted shares of Goodrich Petroleum (NYSE: GDP).

On the downside

Shares of Netlist (Nasdaq: NLST) fell ahead of its earnings release before market open on Friday, March 27.

Investors continued to lock in profits on Cempra (Nasdaq: CEMP).
 
RBC Capital Markets wrote that Nvidia (Nasdaq: NVDA) shifted some of its chip orders from Taiwan Semiconductor (NYSE: TSM) to Samsung Electronics.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 plummeted 30 points to 2061. Bitcoin lost $5 to $243.
The markets continued to drop during the midday with the Dow slumping 216 points to 17,794 as durable goods orders unexpectedly fell. Nasdaq plummeted 88 points to 4,906.

On the upside

The U.S. Consumer Product Safety Commission will investigate the formaldehyde levels in laminates that are made in China that Lumber Liquidators Holdings (NYSE: LL) uses in its flooring products.

Shares of On Track Innovations (Nasdaq: OTIV) rose ahead of its earnings release after market close.

Stamps.com (Nasdaq: STMP) will pay approximately $215 million in cash to acquire Newell Rubbermaid's wholly owned shipping operations subsidiary Endicia.

On the downside

Yingli Green Energy (NYSE: YGE) reported a wider than expected loss for the fourth quarter.

Shares of Esperion Therapeutics (Nasdaq: ESPR) extended its losses.
 
Novavax (Nasdaq: NVAX) will offer $175 million of its common stock through a public offering.

In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by more than 7 to 2 on Nasdaq. The broader S&P 500 tumbled 19 points to 2072. Bitcoin slipped $3 to $244.
An unexpected drop in durable goods orders weighed the markets down to a lower open with the Dow falling 43 points to 17,967. Nasdaq dropped 29 points to 4,965.

On the upside

Kraft Foods (Nasdaq: KRFT) will merge with Heinz to create one of the world's largest food and beverage companies with an annual revenue of $28 billion.

Lexmark (NYSE: LXK) will acquire Kofax (Nasdaq: KFX) in a deal valued at approximately $1 billion.

Vascular Biogenics (Nasdaq: VBLT) narrowed losses for the fourth quarter.

On the downside

Apollo Education Group (Nasdaq: APOL) fell to a loss for the second quarter as revenue dropped and enrollment declined.

EnLink Midstream Partners (NYSE: ENLK) priced its secondary offering of 22.8 million common units at the discounted price of $25.71 per unit.
 
Nationstar Mortgage (NYSE: NSM) priced its offering of 17.5 million common shares.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE while decliners edged out advancers by nearly 5 to 3 on Nasdaq. The broader S&P 500 eased a fraction to 2090. Bitcoin slipped $2 to $245.
New home sales unexpectedly rose last month but the markets tumbled with the Dow plunging 104 points to 18,011 over rate increase concerns. Nasdaq fell 16 points to 4,994.

On the upside

Diplomat Pharmacy (NYSE: DPLO) commenced a follow-on public offering of 7.4 million common shares.

President Barack Obama named former Twitter (NYSE: TWTR) executive Jason Goldman to the newly created position of Chief Digital Officer at the White House.

McDermott (NYSE: MDR) chief executive David Dickson presented at the Howard Weil's Energy Conference today.

On the downside

China Finance Online (Nasdaq: JRJC) reported higher fourth quarter earnings but revenue plunged.

RXi Pharmaceuticals (Nasdaq: RXII) extended its losses.
 
Esperion Therapeutics (Nasdaq: ESPR) closed its follow-on public offering of 2.0125 million common shares.

In the broad market, declining issues outpaced advancers by a margin of 5 to 4 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 fell 12 points to 2091. Bitcoin dropped $16 to $249.
Concerns that Greece only has enough cash to operate for less than a month before it must declare bankruptcy weighed the markets down during the midday with the Dow losing 56 points to 18,059. Nasdaq slipped 2 points to 5,008.

On the upside

The Food and Drug Administration approved Abiomed's (Nasdaq: ABMD) Impella 2.5 heart pump.

The Justice Department declined to intervene in a qui tam action against MiMedx Group (Nasdaq: MDXG).

Barron's wrote last week that OvaScience (Nasdaq: OVAS) had the potential to double.

On the downside

Whiting Petroleum (NYSE: WLL) priced its public offering of 35 million common shares at the discounted price of $30 per share.

The U.S. government is developing a vaccine for the avian flu but has no plans to distribute the vaccine sending shares of Pilgrim's Pride (Nasdaq: PPC) lower.
 
First quarter earnings and revenue rose for IHS (NYSE: IHS) but the results fell short of analyst expectations prompting the company to lower its full year earnings guidance.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and while advancers edged out declines by nearly 10 to 9 on Nasdaq. The broader S&P 500 lost 6 points to 2098. Bitcoin fell $19 to $246. 
The markets opened modestly higher with the Dow adding 8 points to 18,124 as consumer prices edged up 0.2% in February. Nasdaq rose 12 points to 5,023.

On the upside

Digital Ally (Nasdaq: DGLY) narrowed losses for the fourth quarter as revenue soared.

Atossa Genetics (Nasdaq: ATOS) launched its FullCYTE Breast Aspirator in the United States.

Vericel (Nasdaq: VCEL) narrowed fourth quarter losses as revenue surged.

On the downside

Sonus Networks (Nasdaq: SONS) slashed its revenue guidance for the first quarter, warned of losses and initiated a cost structure analysis.

Freeport-McMoRan (NYSE: FCX) blamed lower commodity prices for slashing its quarterly dividend from $0.3125 per share to $0.05 per share.
 
Investors locked in profits on RADA Electronic Industries (Nasdaq: RADA).

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 added a point to 2105. Bitcoin fell $17 to $248.
The markets retreated to close lower with the Dow slipping 11 points to 18,116 despite a gain in existing home sales as investors worried about the global economy. Nasdaq lost 15 points to 5,010.

On the upside

Gramercy Property Trust (NYSE: GPT) completed a 1-for-4 reverse stock split.

Cliffs Natural Resources (NYSE: CLF) will sell its chromite properties to Noront Resources.

Imperial Capital upgraded Callaway Golf (NYSE: ELY) from In-line to Outperform.

On the downside

RXi Pharmaceuticals (Nasdaq: RXII) reported several significant advancements in its dermatology programs but the stock price fell.

A smaller than expected decrease in natural gas inventories weighed down shares of Penn Virginia (NYSE: PVA).
 
Zacks Equity Research recommended selling Oasis Petroleum (NYSE: OAS).

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 5 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 slipped 3 points to 2104. Bitcoin eased a point to $265.

Markets continue rising

|
The markets continued advancing during the midday with the Dow climbing 71 points to 18,188 as existing home sales rose. Nasdaq added 2 points to 5,028.

On the upside

Lockheed Martin selected RADA Electronic Industries' (Nasdaq: RADA) Multi-Mission Hemispheric Radar for a high energy laser weapon system prototype.

Bank of America/Merrill Lynch initiated coverage of CyberArk Software (Nasdaq: CYBR) with a Buy rating and set a $60 price target.

Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) will resume late stage testing of their chronic pain treatment tanezumab.

On the downside

Kansas City Southern (NYSE: KSU) blamed slow growth in the energy sector for lowering its full year revenue guidance.

Wunderlich Securities lowered its price target on Sonus Networks (Nasdaq: SONS) from $22 to $17.
 
Isis Pharmaceuticals (Nasdaq: ISIS) reported positive data from a Phase I study of its antisense drug ANGPTL3 but even stronger results were expected.

In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by nearly 7 to 5 on Nasdaq. The broader S&P 500 rose 5 points to 2113. Bitcoin slipped a point to $265.
Existing home sales edged up 1.2% to lift the markets to a higher open with the Dow gaining 60 points to 18,188. Nasdaq held steady at 5,026.

On the upside

Takeda licensed exclusive rights to ImmunoGen's (Nasdaq: IMGN) ADC technology to develop and commercialize targeted anticancer therapeutics.

Maxim Group initiated coverage of Capnia (Nasdaq: CAPN) with a Buy rating.

Shares of Herbalife (NYSE: HLF) continued soaring.

On the downside

Deutsche Bank downgraded Youku Tudou (NYSE: YOKU) from a Hold rating to a Sell rating and slashed its price target from $18.60 to $10.90.

MEI Pharma (Nasdaq: MEIP) reported disappointing data from a Phase II clinical study of Pracinostat to treat myelodysplastic syndrome.
 
Vertex Pharmaceuticals' (Nasdaq: VRTX) Kalydeco improved lung function in cystic fibrosis patients less than expected.

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE while declining issues edged out advancers by a slim margin on Nasdaq. The broader S&P 500 rose 4 points to 2112. Bitcoin eased a fraction to $266.

Upbeat earnings lift markets

|
Upbeat corporate earnings lifted the markets to a higher close with the Dow surging 168 points to 18,127. Nasdaq climbed 34 points to 5,026.

On the upside

Rally Software Development (NYSE: RALY) widened losses for the fourth quarter but revenue rose to top expectations and the company forecast current quarter revenue ahead of estimates.

NXT-ID's (Nasdaq: NXTD) biometric payment Wocket smart wallet will be featured in 2015 "I Want That" International CES Special to be aired tonight on the DIY Network.

Shares of Herbalife (NYSE: HLF) rose again after a judge dismissed on Monday a shareholder lawsuit alleging that Herbalife operated a pyramid scheme.

On the downside

Zafgen (Nasdaq: ZFGN) widened losses for the fourth quarter.

Shares of Weight Watchers (NYSE: WTW) fell again.
 
Renewed bankruptcy concerns weighed down shares of Mechel (NYSE: MTL).

In the broad market, advancing issues outpaced decliners by a margin of nearly 4 to 1 on the NYSE and by a margin of nearly 3 to 2 on Nasdaq. The broader S&P 500 climbed 18 points to 2108. Bitcoin eased a fraction to $259.

Gains extended at midday

|
The markets extended its gains during the midday with the Dow leaping 190 points to 18,149. Nasdaq soared 41 points to 5,033.

On the upside

Envivio (Nasdaq: ENVI) narrowed losses for the fourth quarter.

Viggle (Nasdaq: VGGL) founder and chief executive Robert F.X. Sillerman offered to acquire 25% of the company's Wetpaint business for $10 million in cash.

Bargain hunters lifted shares of National Bank of Greece (NYSE: NBG).

On the downside

Profit taking weighed down shares of Arotech (Nasdaq: ARTX).

Youku Tudou (NYSE: YOKU) widened losses significantly for the fourth quarter.
 
Investors locked in profits on Coronado Biosciences (Nasdaq: CNDO).

In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by a margin of nearly 2 to 1 on Nasdaq. The broader S&P 500 climbed 19 points to 2109. Bitcoin eased a fraction to $259.

Markets surge as oil climbs

|
The markets surged to a sharply higher open with the Dow soaring 140 points to 18,099 as crude oil prices recovered. Nasdaq climbed 33 points to 5,025.

On the upside

Ctrip (Nasdaq: CTRP) fell to a loss for the fourth quarter but the results were better than expected and the Chinese travel site forecast sharply higher first quarter revenue.

Prothena (Nasdaq: PRTA) reported positive results from a Phase 1 study of its Parkinson's disease treatment PRX002.

Shares of VBL Therapeutics (Nasdaq: VBLT) surged ahead of its presentation today at the BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference.

On the downside

Simon Property Group (NYSE: SPG) made a final offer for Macerich (NYSE: MAC) valued at approximately $23.2 billion including the assumption of debt and expressed disappointment that Macerich had adopted a poison pill earlier this week.

AK Steel Holding (NYSE: AKS) warned of losses for the first quarter.
 
Investors locked in profits on Amicus Therapeutics (Nasdaq: FOLD).

In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by a margin of nearly 5 to 2 on Nasdaq. The broader S&P 500 gained 13 points to 2102. Bitcoin slipped $2 to $258.

Crude oil falls, markets drop

|
Crude oil prices fell again to send the markets tumbling with the Dow plunging 117 points to 17,959. Nasdaq rose 9 points to 4,992.

On the upside

Nevro (NYSE: NVRO) widened losses for the fourth quarter but revenue soared and the company forecast higher full year revenue.

Juno Therapeutics (Nasdaq: JUNO) widened fourth quarter losses more than expected but the company noted that ten of its product candidates will enter clinical development in the next year.

Kite Pharma (Nasdaq: KITE) surged again after announcing on Tuesday that it had acquired privately held T-Cell Factory.

On the downside

Investors locked in profits on Cumulus Media (Nasdaq: CMLS).

Shares of Altisource Portfolio Solutions (Nasdaq: ASPS) extended its losses.
 
RMG Networks (Nasdaq: RMGN) postponed the release of its fourth quarter and full year results and announced that the company has entered into discussions for a possible sale of its media business RMG Airline Media Network.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE while advancers edged out decliners by a margin of 10 to 9 on Nasdaq. The broader S&P 500 fell 10 points to 2089. Bitcoin rose $7 to $259.

Markets drop as oil falls

|
The markets extended its losses during the midday with the Dow plunging 118 points to 17,957 as crude oil prices fell. Nasdaq added 3 points to 4,986.

On the upside

Esperion Therapeutics (Nasdaq: ESPR) priced its public offering of 1.75 million common shares at $100 per share to raise $175 million.

Bargain hunters lifted shares of Willbros Group (NYSE: WG).

Shares of Celladon (Nasdaq: CLDN) climbed after three days of losses.

On the downside

Vince Holding (NYSE: VNCE) reported higher fourth quarter earnings but the company forecast full year result below expectations.

Profit taking weighed down shares of Rex Energy (Nasdaq: REXX).
 
Nucor (NYSE: NUE) cut its first quarter earnings outlook.

In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The broader S&P 500 fell 11 points to 2087. Bitcoin rose $9 to $261. 

Mixed open as jobless claims rise

|
The markets opened mixed with the Dow falling 58 points to 18,018 while Nasdaq gained 10 points to 4,993 as first time applications for unemployment benefits rose modestly.

On the upside

Amicus Therapeutics (Nasdaq: FOLD) accelerated its regulatory approval timeline.

Coronado Biosciences (Nasdaq: CNDO) entered an exclusive license agreement with NeuPharma to develop and commercialize novel irreversible 3rd Generation EGFR inhibitors.

Guess' (NYSE: GES) reported lower fourth quarter earnings but the results were better than expected.

On the downside

Concert Pharmaceuticals (Nasdaq: CNCE) priced its public offering of 3 million common shares at the discounted price of $15.15 per share.

Freeport-McMoRan (NYSE: FCX) stopped production at its Grasberg copper mine in Indonesia as a roadblock by more than 50 workers entered its fourth day.
 
Shares of National Bank of Greece (Nasdaq: NBG) fell as negotiations between Greece and its creditors grew strained.

In the broad market, declining issues outpaced advancers by a margin of 3 to 1 on the NYSE and by more than 5 to 4 on Nasdaq. The broader S&P 500 lost 5 points to 2093. Bitcoin added $4 to $256.
While the Federal Reserve opened the door to a possible increase in interest rates, the Fed also downgraded its economic outlook for the nation sending the markets soaring to a sharply higher close with the Dow rocketing 227 points to 18,076. Nasdaq climbed 45 points to 4,982.

On the upside

Ascent Solar Technologies (Nasdaq: ASTI) expects revenue to more than double in 2015.

Third quarter earnings slipped for Oracle (NYSE: ORCL) but its cloud revenue rose.

TheStreet does not expect Petrobras (Nasdaq: PBR) to declare bankruptcy despite a corruption scandal.

On the downside

MasTec (NYSE: MTZ) delayed filing its annual report due to an ongoing independent internal investigation.

E-House (NYSE: EJ) disappointed with lower fourth quarter earnings.
 
Anthera Pharmaceuticals (Nasdaq: ANTH) priced its public offering of more than 5.5 million common shares at the discounted price of $4.50 per share.

In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 leaped 25 points to 2099. Bitcoin dropped $21 to $260.
Rising crude oil inventories sent the markets tumbling during the midday with the Dow plunging 144 points to 17,704. Nasdaq fell 28 points to 4,908.

On the upside

Shares of Microvision (Nasdaq: MVIS) continued climbing.

Quiksilver (NYSE: ZQK) reported a narrower than expected loss for the first quarter.

Bargain hunters lifted shares of Amarin (Nasdaq: AMRN).

On the downside

Three board members of Chemical & Mining Co. of Chile (NYSE: SQM) resigned amidst a campaign finance scandal.

Concerns about slowing DRAM demand weighed down shares of Mattson Technology (Nasdaq: MTSN).
 
Citigroup cut its price target on FXCM (NYSE: FXCM) from 75 cents to 50 cents.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 dropped 12 points to 2061. Bitcoin tumbled $19 to $261.
The markets opened lower with the Dow falling 67 points to 17,781 ahead of the Federal Reserve's statement. Nasdaq lost 9 points to 4,927.

On the upside

Vitesse Semiconductor (Nasdaq: VTSS) will be acquired by Microsemi (Nasdaq: MSCC) for a premium of $5.28 per share in cash.

Novogen (Nasdaq: NVGN) reported that its Anisina demonstrated potential to destroy a cancer cell's cytoskeleton.

Retrophin (Nasdaq: RTRX) will acquire the worldwide rights to the first Food and Drug Adminstration approved pediatric and adult patients with bile acid synthesis disorders treatment Cholban.

On the downside

Willbros Group (NYSE: WG) delayed filing its annual report.

Nektar Therapeutics (Nasdaq: NKTR) reported disappointing results from a Phase 3 clinical study of its advanced breast cancer treatment NKTR-102.
 
RSP Permian (NYSE: RSPP) priced its public offering of 5 million common shares at the discounted price of $25.80 per share.

In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on both the NYSE and on Nasdaq. The broader S&P 500 slipped 4 points to 2069. Bitcoin fell $13 to $268.

Markets drop over rate concerns

|
Concerns about an interest rate increase sent the markets down to a lower close with the Dow plummeting 128 points to 17,849. Nasdaq rose 7 points to 4,937.

On the upside

Qunar Cayman Islands (Nasdaq: QUNR) widened losses for the fourth quarter but revenue more than doubled.

Veeva Systems (NYSE: VEEV) was selected to be GSK's global multichannel CRM partner.

JinkoSolar (NYSE: JKS) reported that there were no casualties from a fire at a raw material processing workshop and the incident would have no material impact on operations, financials or delivery commitments.

On the downside

magicJack VocalTec (Nasdaq: CALL) widened fourth quarter losses more than expected.

CHC Group (NYSE: HELI) disappointed by widening losses significantly for the fourth quarter.
 
StemCells (Nasdaq: STEM) widened losses for the fourth quarter.

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by 5 to 4 on Nasdaq. The broader S&P 500 slipped 6 points to 2074. Bitcoin lost $4 to $284.
The markets traded lower during the midday with the Dow tumbling 102 points to 17,874 as rate concerns resurfaced. Nasdaq edged up a fraction to 4,930.

On the upside

Esperion Therapeutics (Nasdaq: ESPR) reported positive results from a Phase 2b study of ETC-1002 to lower LDL-cholesterol.

Arotech (Nasdaq: ARTX) swung to a better than expected profit for the fourth quarter.

Arcos Dorados (NYSE: ARCO) reported lower fourth quarter earnings but comparable sales rose.

On the downside

Vaalco Energy (NYSE: EGY) fell to a loss for the fourth quarter.

Discovery Laboratories (Nasdaq: DSCO) reported a loss for the fourth quarter.
 
Avid (Nasdaq: AVID) fell to a fourth quarter loss.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 slipped 6 points to 2074. Bitcoin lost $4 to $284.
A sharp drop in housing starts sent the markets tumbling to a sharply lower open with the Dow plunging 151 points to 17,825. Nasdaq lost 12 points to 4,916.

On the upside

Land and Buildings said that MGM Resorts International (NYSE: MGM) was undervalued and suggested that the casino operator convert into a real estate investment trust.

Black Diamond (Nasdaq: BDE) retained the services of Rothschild and Robert W. Baird to explore strategic alternatives prompting upgrades.

American Airlines Group (Nasdaq: AAL) will replace Allergan (NYSE: AGN) on the S&P 500 index after market close on Friday, March 20.

On the downside

Plug Power (Nasdaq: PLUG) reported a wider than expected loss for the fourth quarter.

Investors locked in profits on Amarin (Nasdaq: AMRN).
 
RBC Capital Markets lowered its price target on Micron Technology (Nasdaq: MU) from $44 to $40.

In the broad market, declining issues outpaced advancers by a margin of 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 lost 9 points to 2071. Bitcoin eased $1 to $286.

Markets soar as euro strengthens

|
The rising euro sent the markets soaring to a sharply higher close with the Dow rocketing 228 points to 17,977. Nasdaq leaped 57 points to 4,929.

On the upside

Sterling Construction (Nasdaq: STRL) narrowed losses for the fourth quarter and amended its credit facility.

Bezinga noted that Maxim has a Buy rating on Cytori Therapeutics (Nasdaq: CYTX) with a $7 price target.

Shares of Martha Stewart Living Omnimedia (NYSE: MSO) continued rising.

On the downside

Progenics Pharmaceuticals (Nasdaq: PGNX) widened fourth quarter losses.

Bank of America downgraded DuPont (NYSE: DD) from a Buy rating to a Neutral rating.
 
Falling crude oil prices weighed down shares of Swift Energy (NYSE: SFY).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 5 to 4 on Nasdaq. The broader S&P 500 surged 27 points to 2081. Bitcoin rose $4 to $288.

Markets continue soaring at midday

|
The markets extended its gains during the midday with the Dow leaping 182 points to 17,932. Nasdaq soared 40 points to 4,912.

On the upside

Inovio Pharmaceuticals (Nasdaq: INO) narrowed fourth quarter losses more than expected and announced that it received a five year $16 million Integrated Preclinical/Clinical AIDS Vaccine Development Program grant.

Advaxis (Nasdaq: ADXS) reported upbeat preliminary data from a Phase 1/2 clinical study of its immunotherapy ADXS-HPV.

Edwards Lifesciences (NYSE: EW) reported low mortality rates at 30-days for the SAPIEN 3 transcatheter aortic valve.

On the downside

iDreamSky (Nasdaq: DSKY) lowered its fourth quarter revenue guidance prompting a downgrade.

An appeals court reversed-in-part and vacated-in-part a judgment in Enzo Biochem's (NYSE: ENZ) favor that Life Technologies (Nasdaq: LIFE) infringed on Enzo's patents.
 
Anthera Pharmaceuticals (Nasdaq: ANTH) reported a loss for the fourth quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by 5 to 4 on Nasdaq. The broader S&P 500 soared 20 points to 2073. Bitcoin added $3 to $288. 

Strengthening euro boosts markets

|
A strengthening euro lifted the markets to a sharply higher open with the Dow surging 173 points to 17,922. Nasdaq climbed 39 points to 4,910.

On the upside

24/7 Wall Street noted that HC Wainwright lifted its price target on Amarin (Nasdaq: AMRN) from $2.50 to $10 on Thursday.

Microvision (Nasdaq: MVIS) received orders totaling $14.5 million.

Kandi Technologies (Nasdaq: KNDI) swung to a profit for 2014 as revenue nearly doubled.

On the downside

Profit taking weighed down shares of Mechel (NYSE: MTL).

Shares of SeaDrill (NYSE: SDRL) continued falling as crude oil extended its losses.
 
S&P Dow Jones Indices downgraded Avon (Nasdaq: AVP) from its S&P 500 index to the MidCap 400 Index.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 climbed 18 points to 2071. Bitcoin rose $7 to $291.
Falling crude oil prices along with an unexpected drop in consumer sentiment sent the markets tumbling to a sharply lower close with the Dow plunging 145 points to 17,749. Nasdaq dropped 21 points to 4,871.

On the upside

Bloomberg reported that Investment Technology Group (NYSE: ITG) engaged in discussions to acquire Convergex.

Anacor Pharmaceuticals (Nasdaq: ANAC) reported to a smaller than expected loss for the fourth quarter.

Shares of Violin Memory (NYSE: VMEM) continued rising.

On the downside

Quantum Technologies (Nasdaq: QTWW) reported a loss for the fourth quarter.

Brazilian federal prosecutors will investigate current Rio de Janeiro governor Luiz Fernando Pezao and former governor Sergio Cabral in a corruption scandal involving Petroleo Brasileiro (NYSE: PBR).
 
Ignite Restaurant Group (Nasdaq: IRG) widened losses significantly for the fourth quarter.

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 3 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 fell 12 points to 2053. Bitcoin slipped $4 to $282.

Losses extended as oil drops

|
The markets extended its losses during the midday with the Dow plummeting 218 points to 17,676 as crude oil prices dropped. Nasdaq tumbled 41 points to 4,851.

On the upside

Shares of Amarin (Nasdaq: AMRN) continued rising.

Ebix (Nasdaq: EBIX) reported higher fourth quarter earnings and revenue that beat analyst expectations.

Repligen (Nasdaq: RGEN) fell to a loss for the fourth quarter but revenue rose and the company forecast higher full year revenue.

On the downside

Civeo (NYSE: CVEO) fell to a loss for the fourth quarter on lower revenue.

Citi Trends (Nasdaq: CTRN) announced the retirement of chief executive Ed Anderson.
 
Basic Energy Services (NYSE: BAS) reported sharply lower rig utilization rates for February.

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 dropped 18 points to 2047. Bitcoin slipped $2 to $289.
An unexpected drop in March consumer sentiment sent the markets tumbling to a sharply lower open with the Dow plunging 133 points to 17,761. Nasdaq lost 17 points to 4,875.

On the upside

FXCM (NYSE: FXCM) reported sharply higher fourth quarter earnings that topped analyst estimates as revenue rose.

El Pollo Loco (Nasdaq: LOCO) reversed year ago losses to post a stronger than expected profit for the fourth quarter.

The Wall Street Journal reported that the Federal Bureau of Investigation questioned individuals associated with billionaire investor Bill Ackman for making false statements in order to manipulate Herbalife (NYSE: HLF) stock.

On the downside

Galena Biopharma (Nasdaq: GALE) priced its public offering of approximately 24.36 million units at the discounted price of $1.56 per unit.

CTI BioPharma (Nasdaq: CTIC) fell to a loss for the fourth quarter as revenue plunged.

Aeropostale (NYSE: ARO) narrowed losses for the fourth quarter but the teen apparel retailer forecast a greater than expected loss for the current quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by 7 to 3 on Nasdaq. The broader S&P 500 fell 11 points to 2054. Bitcoin slipped $2 to $290.
The markets surged after two days of losses to close sharply higher with the Dow rocketing 259 points to 17,895 as all major U.S. banks passed the annual stress test. Nasdaq soared 43 points to 4,893.

On the upside

Epizyme (Nasdaq: EPZM) fell to a loss for the fourth quarter but the results were better than expected.

Integrated Silicon Solution (Nasdaq: ISSI) will be acquired by a consortium of investors led by Summitview Capital in a cash deal valued at approximately $639.5 million.

Citigroup (NYSE: C) passed the Federal Reserve's stress test, increased its quarterly dividend  and announced plans to repurchase up to $7.8 billion in stock.

On the downside

Comtech Telecommunications (Nasdaq: CMTL) reported higher second quarter earnings but the company forecast current quarter earnings and revenue that missed analyst expectations.

Ply Gem (NYSE: PGEM) reported a wider than expected loss for the fourth quarter.

Inogen (Nasdaq: INGN) delayed the release of its fourth quarter and full year financial report due to an ongoing internal investigation into its accounting practices.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by 7 to 3 on Nasdaq. The broader S&P 500 surged 25 points to 2065. Bitcoin added a fraction to $294.
Jobless claims fell more than expected to boost the markets sharply higher during the midday with the Dow leaping 191 points to 17,826. Nasdaq climbed 30 points to 4,880.

On the upside

Bon-Ton Stores (Nasdaq: BONT) reported higher fourth quarter earnings as revenue rose.

Shares of Summit Materials (NYSE: SUM) surged in its market debut.

Lumber Liquidators (NYSE: LL) defended the safety of its products and offered free air quality testing and free re-installations to customers.

On the downside

PetroQuest Energy (NYSE: PQ) will not proceed with its previously announced public offering of 10 million common shares.

Profit taking weighed down shares of Warren Resources (Nasdaq: WRES).

Second Sight Medical Products (Nasdaq: EYES) widened losses for the fourth quarter.

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 soared 18 points to 2058. Bitcoin added a point to $294.
A greater than expected drop in first time applications for unemployment benefits sent the markets soaring with the Dow surging 166 points to 17,802. Nasdaq climbed 23 points to 4,873.

On the upside

HC Wainwright upgraded Amarin (Nasdaq: AMRN) from a Neutral rating to a Buy rating and lifted its price target from $2.50 to $10.

Men's Wearhouse (NYSE: MW) reported a narrower than expected loss for the fourth quarter.

Penn West Petroleum (NYSE: PWE) declared a quarterly dividend of a penny per share payable on April 15, 2015 to shareholders of record March 31, 2015.

On the downside

ACADIA Pharmaceuticals (Nasdaq: ACAD) delayed the submission of a New Drug Application for its Parkinson's disease psychosis treatment NUPLAZID until the second half of 2015 and announced the immediate retirement of chief executive Uli Hacksell, Ph.D.

Box (NYSE: BOX) widened losses more than expected.

CyberArk Software (Nasdaq: CYBR) priced its secondary public offering of 4 million common shares at the discounted price of $51 per share.

In the broad market, advancing issues outpaced decliners by a margin of 6 to 1 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 climbed 15 points to 2055. Bitcoin eased a fraction to $293. 
The markets retreated to close modestly lower with the Dow losing 27 points to 17,635 as U.S. oil inventories surged to a record high. Nasdaq slipped 9 points to 4,849.

On the upside

Chesapeake Energy (NYSE: CHK) said that it was more efficient at drilling its Utica wells than its peers.

Capnia (Nasdaq: CAPN) widened losses for the fourth quarter but the stock price rose as the company continued to expand commercial sales of its CoSense end-tidal carbon monoxide monitors.

Covenant Transportation Group (Nasdaq: CVTI) expects to report first quarter earnings well above analyst expectations.

On the downside

Blount International (NYSE: BLT) reported a loss for the fourth quarter.

The looming prospect of water rationing in southeastern Brazil sent shares of chemicals maker Braskem (NYSE: BAK) tumbling.

Profit taking weighed down shares of Cytori Therapeutics (Nasdaq: CYTX).

In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 5 on both the NYSE and on Nasdaq. The broader S&P 500 slipped 3 points to 2040. Bitcoin added $1 to $292.

Bargain hunters lift markets

|
Bargain hunters lifted the markets higher during the midday with the Dow rising 54 points to 17,717. Nasdaq added 5 point to 4,865.

On the upside

CNBC reported that Chapman Capital chief executive Robert Chapman took a long position in Lumber Liquidators (NYSE: LL).

Venture Beat reported that Apple (Nasdaq: AAPL) will use Intel's (NYSE: INTC) 7360 LTE modem in iPhones for the Asian and Latin America markets.

Mylan (Nasdaq: MYL) launched generic versions of Antabuse and Subutex Sulingual Tablets and introduced three additional dosage strengths for its Fentanyl Transdermal System.

On the downside

Sunoco Logistics (NYSE: SXL) priced its public offering of 13.5 million common units at the discounted price of $41.76 per unit.

A suspected case of bird flu in Arkansas sent shares of Tyson Foods (NYSE: TSN) tumbling.

Wells Fargo downgraded EMC (NYSE: EMC) from an Outperform rating to a Market Perform rating.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on both the NYSE and on Nasdaq. The broader S&P 500 added 3 points to 2047. Bitcoin added $1 to $292.
The markets opened higher with the Dow gaining 49 points to 17,712 as Greek officials met with international creditors. Nasdaq added 6 points to 4,866.

On the upside

MELA Sciences (Nasdaq: MELA) welcomed the addition of Category III codes to report multispectral digital skin lesion analysis of atypical cutaneous lesions.

Supernus Pharmaceuticals (Nasdaq: SUPN) swung to a better than expected profit for the fourth quarter.

Fourth quarter earnings fell for Warren Resources (Nasdaq: WRES) but the results were better than expected.

On the downside

Zogenix (Nasdaq: ZGNX) narrowed losses for the fourth quarter but the company did not provide guidance for 2015 and announced plans to sell its Zohydro pain treatment business to Pernix.

Memorial Resource Development (Nasdaq: MRD) reversed year ago losses to post a profit for the fourth quarter but the stock price fell.

Fourth quarter earnings slipped for Vera Bradley (Nasdaq: VRA) to miss analyst expectations .

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 added 3 points to 2047. Bitcoin eased a fraction to $291.
The negative impact of a strong dollar on corporate earnings along with concerns about a rate hike sent the markets into a free fall with the Dow collapsing 332 points to 17,662. Nasdaq crashed 82 points to 4,859.

On the upside

Speculation that Acadia Pharmaceuticals (Nasdaq: ACAD) may be acquired lifted shares of the biopharmaceutical.

Shares of Pinnacle Entertainment (NYSE: PNK) continued rising.

Quiksilver (NYSE: ZQK) shareholder Ryan Drexler made a second request that the company sell itself.

On the downside

Jefferies downgraded AcelRx Pharmaceuticals (Nasdaq: ACRX) from a Buy rating to a Hold rating and slashed its price target from $12 to $6.

Second quarter earnings slipped for IDT (NYSE: IDT) as revenue fell.

Barnes & Noble (NYSE: BKS) reported higher third quarter earnings but the results fell short of analyst expectations.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 plunged 35 points to 2044. Bitcoin added $4 to $292.
The markets extended its steep losses during the midday with the Dow crashing 254 points to 17,741 as the dollar climbed to a 12-year high against the euro. Nasdaq dove 69 points to 4,873.

On the upside

Shares of Geron (Nasdaq: GERN) extended its gains.

Cytori Therapeutics (Nasdaq: CYTX) chief executive Dr. Marc H. Hedrick will present today at the 27th Annual ROTH Conference.

Western Alliance Bancorporation will acquire Bridge Capital Holdings (Nasdaq: BBNK) in a cash and stock deal valued at approximately $425 million.

On the downside

Westport Innovations (Nasdaq: WPRT) reported a wider than expected loss for the fourth quarter.

Shares of BioScrip (Nasdaq: BIOS) extended its losses.

NN (Nasdaq: NNBR) disappointed with sharply lower fourth quarter earnings that missed analyst expectations and forecast full year revenue below estimates.

In the broad market, declining issues outpaced advancers by a margin of nearly 3 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The broader S&P 500 plummeted 27 points to 2051. Bitcoin added $4 to $292.
Sales at wholesale businesses dropped 3.1% in January to send the markets tumbling to a sharply lower open with the Dow collapsing 229 points to 17,765. Nasdaq plummeted 65 points to 4,876.

On the upside

Fourth quarter earnings slipped for Urban Outfitters (Nasdaq: URBN) but the results were better than expected.

Lumber Liquidators (NYSE: LL) will hold a conference call on Thursday to discuss product safety, provide an updated outlook for the first quarter and announce plans to focus on its customers.

Credit Suisse (NYSE: CS) named Tidjane Thiam to the position of chief executive officer.

On the downside

Akorn (Nasdaq: AKRX) affirmed its full year outlook but the stock price plunged after three more class action lawsuits were filed against the company yesterday.

Callon Petroleum (NYSE: CPE) priced its public offering of 9 million shares of common stock at a discounted price to raise nearly $59 million.

Calumet Specialty Products Partners (Nasdaq: CLMT) priced its public offering of 6 million common units at the discounted price of $26.75 per unit.

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by 5 to 1 on Nasdaq. The broader S&P 500 plunged 24 points to 2055. Bitcoin added $3 to $290.
The markets closed sharply higher with the Dow soaring 138 points to 17,995 as the European Central Bank began buying bonds. Nasdaq rose 15 points to 4,942.

On the upside

Sterling Construction (Nasdaq: STRL) named Paul J. Varello to the position of chief executive officer.

FBR Capital Markets upgraded UTi Worldwide (Nasdaq: UTIW) from a Market Perform rating to an Outperform rating and lifted its price target from $11 to $19.

Shares of Westport Innovations (Nasdaq: WPRT) rose ahead of its earnings release after market close.

On the downside

BioScrip (Nasdaq: BIOS) will offer $20 million worth of preferred stock and warrants.

Midstates Petroleum (NYSE: MPO) interim president and chief executive officer Dr. Peter J. Hill resigned.

Sky-mobi (Nasdaq: MOBI) reported higher fourth quarter earnings and revenue but the stock price fell.

In the broad market, advancing issues outpaced decliners by a margin of 10 to 9 on the NYSE and by 5 to 4 on Nasdaq. The broader S&P 500 gained 8 points to 2079. Bitcoin climbed $12 to $285.

M&A activity boosts markets

|
Merger and acquisition activity boosted the markets during the midday with the Dow surging 146 points to 18,002. Nasdaq gained 13 points to 4,940.

On the upside

Gaming and Leisure Properties (NYSE: GLPI) offered to buy Pinnacle Entertainment's (NYSE: PNK) real estate assets in a deal valued at approximately $4.1 billion including the assumption of debt.

Green Plains (Nasdaq: GPRE) subsidiary Green Plains Partners filed for a proposed initial public offering.

RBC Capital upgraded AVEO Pharmaceuticals (Nasdaq: AVEO) from an Underperform rating to a Sector Perform rating.

On the downside

Meru Networks (Nasdaq: MERU) reported a loss for the fourth quarter.

Shares of Lumber Liquidators (NYSE: LL) fell again as another lawsuit was filed against the company.

Another class action lawsuit was filed against 500.com (NYSE: WBAI).

In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 climbed 9 points to 2080. Bitcoin rose $12 to $285.
The markets opened higher with the Dow climbing 79 points to 17,935 as the European Central Bank began its bond buying program. Nasdaq rose 7 points to 4,934.

On the upside

Alcoa (NYSE: AA) will pay a premium of approximately $1.5 billion in stock to acquire RTI International Metals (NYSE: RTI).

The Wall Street Journal reported on Friday that Whiting Petroleum (NYSE: WLL) was selling itself.

RMG Networks (Nasdaq: RMGN) reported strong preliminary fourth quarter adjusted revenue.

On the downside

The Food and Drug Administration requested that AcelRx (Nasdaq: ACRX) conduct an additional clinical study for its pain medication Zalviso.

Bitauto (NYSE: BITA) reported higher fourth quarter earnings and revenue but the stock price fell.

Retreating crude oil prices weighed down shares of Chesapeake Energy (NYSE: CHK) and Petrobras (NYSE: PBR).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 gained 5 points to 2076.

Rate concerns sink stocks

|
Fears of an imminent interest rate increase sent the markets plunging to a sharply lower close with the Dow tanking 278 points to 17,856. Nasdaq plummeted 55 points to 4,927.

On the upside

Roth Capital Partners initiated coverage of Celladon (Nasdaq: CLDN) with a Buy rating and a price target of $70.

Diamond Foods (Nasdaq: DMND) reversed year ago losses to post a greater than expected profit for the second quarter.

Retrophin (Nasdaq: RTRX) widened losses for the second quarter but the company reported significant second quarter revenue compared with no revenue last year.

On the downside

Esterline Technologies (NYSE: ESL) disappointed with lower first quarter earnings that fell far short of analyst expectations as revenue dropped.

Falling gold and silver prices weighed down shares of Harmony Gold (NYSE: HMY) and Hecla Mining (NYSE: HL).

Violin Memory (NYSE: VMEM) narrowed losses for the fourth quarter but revenue fell to miss analyst estimates.

In the broad market, declining issues outpaced advancers by a margin of nearly 6 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 plummeted 29 points to 2071. Bitcoin held steady at $271.
Concerns that the Federal Reserve would cite nation's strong job market for raising interest rates sent the markets plummeting during the midday with the Dow collapsing 258 points to 17,877. Nasdaq plunged 49 points to 4,933.

On the upside

The Wall Street Journal reported that Life Time Fitness (NYSE: LTM) was engaged in negotiations with two separate groups to take the company private.

Calithera Biosciences (Nasdaq: CALA) secured the exclusive worldwide rights to research, develop and commercialize TransTech Pharma's hexokinase II inhibitors.

Forbes contributor Elaine Schattner noted that March was colorectal cancer awareness month and highlighted the benefits of Exact Sciences' (Nasdaq: EXAS) noninvasive screening test Cologuard.

On the downside

A Food and Drug Administration official questioned the reliability of recent study results released by Orexigen (Nasdaq: SSH) indicating that its obesity treatment Contrave reduced the risk of heart attacks.

Shares of MaxPoint (NYSE: MXPT) fell on its first trading day.

Checkpoint Systems (NYSE: CKP) swung to a profit for the fourth quarter but revenue fell and the company forecast full year earnings and revenue below expectations.

In the broad market, declining issues outpaced advancers by a margin of nearly 6 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 plunged 27 points to 2073. Bitcoin eased $1 to $270.
The nation's unemployment rate fell to 5.5% in February but the markets tumbled with the Dow dropping 78 points to 18,057 over concerns that the Federal Reserve would raise interest rates. Nasdaq slipped 2 points to 4,980.

On the upside

AVEO Oncology (Nasdaq: AVEO) narrowed fourth quarter losses.

YY (Nasdaq: YY) reported higher sharply fourth quarter earnings that beat expectations.

Finisar (Nasdaq: FNSR) reported sharply lower third quarter earnings but revenue rose to top estimates and the company forecast current quarter earnings and revenue ahead of expectations.

On the downside

Sunshine Heart (Nasdaq: SSH) will temporarily halt enrollment in a study of the C-Plus heart assist system.

BioLineRx (Nasdaq: BLRX) priced its offering of 12.5 million American Depositary Shares at the discounted price of $2 per ADS.

Investors locked in profits of Genetic Technologies (Nasdaq: GENE).

In the broad market, declining issues outpaced advancers by a margin of nearly 3 to 1 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 lost 7 points to 2093. Bitcoin held steady at $272.
The European Central Bank announced plans to initiate its stimulus plan on Monday which lifted the markets to a higher close with the Dow rising 38 points to 18,135. Nasdaq gained 15 points to 4,982.

On the upside

Golar LNG (Nasdaq: GLNG) entered a Memorandum of Understanding with Rosneft Oil for cooperation in the area of floating liquefaction and transportation of natural gas.

Canadian Solar (Nasdaq: CSIQ) reported sharply higher fourth quarter earnings and revenue.

PowerSecure International (NYSE: POWR) swung to a profit for the fourth quarter.

On the downside

Semtech (Nasdaq: SMTC) fell to a loss for the fourth quarter.

First quarter earnings and revenue slipped for Greif (NYSE: GEF) to fall short of analyst expectations.

Rite Aid (NYSE: RAD) reported a same store sales increase of 3.3% for the month of February but the pace slowed from January's 4.8% growth.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 rose 2 points to 2101. Bitcoin added $6 to $276.
The markets traded higher during the midday with the Dow rising 34 points to 18,131 after the European Central Bank lifted its eurozone growth forecast from 1% to 1.5%. Nasdaq added 12 points to 4,979.

On the upside

The Food and Drug Administration released briefing documents for Kythera Biopharma's (Nasdaq: KYTH) ATX-101 indicating a favorable benefit-risk assessment.

Vivint Solar (NYSE: VSLR) reported a smaller than expected loss for the fourth quarter.

Geron (Nasdaq: GERN) narrowed losses for the fourth quarter.

On the downside

Capnia (Nasdaq: CAPN) closed a transaction for Series B warrant holders to exercise their warrants and issued new Series C warrants.

Eclipse Resources (NYSE: ECR) widened losses for the fourth quarter.

Momo (Nasdaq: MOMO) widened fourth quarter losses.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 added a point to 2099. Bitcoin slipped $5 to $264.
Investors welcomed the European Central Bank's plan to begin buying government bonds on March 9. The markets opened higher with the Dow gaining 44 points to 18,141 and Nasdaq climbing 21 points to 4,988.

On the upside

Second Sight Medical Products (Nasdaq: EYES) announced the first successful implants of their Argus II Retinal Prosthesis System at two centers in Italy.

AbbVie (NYSE: ABBV) will pay a premium of approximately $21 billion to purchase Pharmacyclics (Nasdaq: PCYC).

Pacific Ethanol (Nasdaq: PEIX) reported higher fourth quarter earnings as revenue rose.

On the downside

Achillion Pharmaceuticals (Nasdaq: ACHN) widened losses for the fourth quarter.

Embraer (NYSE: ERJ) disappointed with sharply lower fourth quarter earnings as revenue fell.

Darling Ingredients (NYSE: DAR) reported sharply higher fourth quarter earnings and revenue but the stock price dropped.

In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 added 4 points to 2103. Bitcoin slipped $1 to $268.
Disappointing jobs data weighed the markets down to a sharply lower close with the Dow plunging 106 points to 18,096. Nasdaq fell 12 points to 4,967.

On the upside

Career Education (Nasdaq: CECO) narrowed fourth quarter losses more than expected.

Shares of Capnia (Nasdaq: CAPN) continued rising.

Orexigen Therapeutics (Nasdaq: OREX) stock extended its gains.

On the downside

Quicksilver (NYSE: ZQK) delayed the release of its first quarter financials.

Profit taking weighed down shares of StemCells (Nasdaq: STEM).

Xplore Technologies (Nasdaq: XPLR) priced its offering of 2 million shares of common stock at the discounted price of $6 per share.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 lost 9 points to 2098. Bitcoin fell $11 to $268.
The markets traded lower during the midday with the Dow tumbling 99 points to 18,104 as oil prices fell and jobs data disappointed. Nasdaq lost 13 points to 4,966.

On the upside

Coronado Biosciences (Nasdaq: CNDO) formed a new subsidiary, Checkpoint Therapeutics, to develop immuno-oncology antibodies.

Wayfair (NYSE: W) widened losses for the fourth quarter but the results were better than expected.

Autohome (NYSE: ATHM) impressed with fourth quarter earnings that more than doubled as revenue surged.

On the downside

Fourth quarter earnings and revenue fell for Abercrombie & Fitch (NYSE: ANF).

Cyclacel Pharmaceuticals (Nasdaq: CYCC) priced its public offering of 10 million common shares at the discounted price of $1.00 per share.

TriNet Group (NYSE: TNET) reported higher fourth quarter earnings and revenue but the stock price fell after Deutsche Bank cut its price target on the company from $40 to $35.

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 lost 9 points to 2098. Bitcoin held steady at $279.
The nation's private employers added fewer than expected jobs in February sending the markets tumbling to a sharply lower open with the Dow plunging 156 points to 18,046. Nasdaq dropped 35 points to 4,944.

On the upside

Novogen (Nasdaq: NVGN) announced that TRXE-009 demonstrated potential to kill brain cancer stem cells.

InfoSonics (Nasdaq: IFON) reported sharply higher fourth quarter earnings as revenue soared.

Third quarter earnings and revenue dropped for Smith & Wesson (Nasdaq: SWHC) but the results were better than expected.

On the downside

Veeva Systems (NYSE: VEEV) reported higher fourth quarter earnings and revenue but the stock price fell when the company announced plans to acquire Qforma CrowdLink for an undisclosed amount.

Bazaarvoice (Nasdaq: BV) reported a loss for the third quarter.

Bob Evans Farms (Nasdaq: BOBE) reported lower third quarter earnings even as revenue rose.

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 tumbled 18 points to 2088. Bitcoin added $1 to $280.
The markets closed lower with the Dow tumbling 85 points to 18,203 as February auto sales disappointed. Nasdaq fell 28 points to 4,979.

On the upside

Intrexon (NYSE: XON) reversed year ago losses to post a profit for the fourth quarter as revenue quadrupled.

MarketWatch listed Capnia (Nasdaq: CAPN) as one of the most profitable Nasdaq biotech companies.

DTS (Nasdaq: DTSI) reported sharply lower fourth quarter earnings but the results were better than expected.

On the downside

Primoris Services (Nasdaq: PRIM) disappointed with sharply lower fourth quarter earnings that fell far short of analyst expectations.

NorthStar Realty Finance (NYSE: NRF) priced its public offering of 60 million common shares at the discounted price of $18.65 per share.

Nomura downgraded Micron Technology (Nasdaq: MU) from a Buy rating to a Neutral rating.

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 lost 9 points to 2107. Bitcoin gained $9 to $278.
Disappointing February auto sales sent the markets tumbling during the midday with the Dow plunging 108 points to 18,180. Nasdaq dropped 39 points to 4,968.

On the upside

Orexigen Therapeutics' (Nasdaq: OREX) obesity treatment Contrave reduced the risk of heart disease by almost half.

Nutrisystem (Nasdaq: NTRI) reported sharply higher fourth quarter earnings that topped analyst estimates.

Janney Capital Markets analyst David Strasser upgraded Lumber Liquidators Holdings (NYSE: LL) from a Neutral rating to a Buy rating and affirmed his $47 price target.

On the downside

Opower (NYSE: OPWR) widened losses for the fourth quarter.

SunOpta (Nasdaq: STKL) widened fourth quarter losses more than expected.

Akorn (Nasdaq: AKRX) filed for an extension for its Form 10-K.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more nearly 2 to 1 on Nasdaq. The broader S&P 500 dropped 13 points to 2103. Bitcoin added $4 to $273.

Lower open as oil prices slide

|
Retreating crude oil prices weighed the markets down to a lower open with the Dow dropping 70 points to 18,218. Nasdaq fell 24 points to 4,983.

On the upside

The Food and Drug Administration granted Orphan Drug Designation to Oncolytics Biotech's (Nasdaq: ONCY) primary peritoneal cancer treatment Reolysin.

McDermott International (NYSE: MDR) reversed year ago losses to post an unexpected profit for the fourth quarter as revenue soared.

Springleaf Holdings (NYSE: LEAF) will pay approximately $4.25 billion in cash to acquire Citigroup's (NYSE: C) OneMain Financial Holdings consumer finance unit.

On the downside

Goldman Sachs downgraded MannKind (Nasdaq: MNKD) from a Neutral rating to a Sell rating and slashed its price target from $6 to $3.

Cumulus Media (Nasdaq: CMLS) disappointed with sharply lower fourth quarter earnings that fell short of expectations.

Arena Pharmaceuticals (Nasdaq: ARNA) widened losses for the fourth quarter.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 fell 9 points to 2107. Bitcoin lost $3 to $265.

Strong March open

|
The month of March began strong with the Dow jumping 155 points to 18,288. Nasdaq soared 44 points to close at 5,008, topping 5,000 for the first time in fifteen years.

On the upside

Tracon Pharmaceuticals (Nasdaq: TCON) reported positive results from a Phase 1b clinical trial of TRC105 with Inlyta(R) in patients with advanced or metastatic renal cell carcinoma.

Cisco Systems (Nasdaq: CSCO) introduced its Universal Small Cell (USC) 8000 Series for large enterprises.

Bargain hunters lifted shares of 500.com (NYSE: WBAI).

On the downside

Goodrich Petroleum (NYSE: GDP) will offer 12 million shares of common stock.

BioScrip (Nasdaq: BIOS) widened fourth quarter losses more than expected.

The Food and Drug Administration issued a Complete Response Letter to Pacira Pharmaceuticals (Nasdaq: PCRX) for its supplemental New Drug Application for the expanded use of Exparel.

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 climbed 12 points to 2117. Bitcoin climbed $16 to $271.

Markets extend gains

|
The markets extended its gains during the midday with the Dow surging 119 points to 18,252. Nasdaq gained 29 points to 4,992.

On the upside

Ohr Pharmaceutical (Nasdaq: OHRP) presented additional positive data from the IMPACT study interim analysis at the 38th Annual Macula Society Meeting.

Dr. David Rimm, professor of pathology and professor of medicine in medical oncology at Yale University School of Medicine will join Biocept (Nasdaq: BIOC) as a scientific advisor.

GrafTech International (NYSE: GTI) widened losses for the fourth quarter but the results were better than expected.

On the downside

A "60 Minutes" segment reported that Lumber Liquidators (NYSE: LL) sold laminate flooring that contained formaldehyde levels that were several times the legal limit.

Kosmos Energy (NYSE: KOS) must plug and abandon its CB-1 exploration well after encountering hydrocarbons.

Mitel (Nasdaq: MITL) will acquire Mavenir Systems (NYSE: MVNR) in a deal valued at approximately $560 million.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 gained 8 points to 2112. Bitcoin added $5 to $260.
The markets opened sharply higher with the Dow soaring 108 points to 18,241 after Greece received an extension of its bailout last week. Nasdaq climbed 32 points to 4,995.

On the upside

NXP Semiconductors (Nasdaq: NXPI) will pay approximately $11.8 billion in cash and stock to acquire Freescale Semiconductor (NYSE: FSL).

Athersys (Nasdaq: ATHX) entered an exclusive partnership with Chugai Pharmaceuticals to develop and commercialize MultiStem cell therapy for ischemic stroke in Japan.

FN Media Group named Cyclacel Pharmaceuticals (Nasdaq: CYCC) as one of several nutraceutical and biotech companies developing treatments for lifestyle related disorders.

On the downside

Compass Point downgraded Navient (Nasdaq: NAVI) from a Buy rating to a Neutral rating.

Profit taking continued to weigh down shares of Cytori Therapeutics (Nasdaq: CYTX).

Shares of National Bank of Greece (NYSE: NBG) fell despite a debt extension last week.

In the broad market, advancing issues outpaced decliners by a margin of 3 to 2 on the NYSE and by 2 to 1 on Nasdaq. The broader S&P 500 gained 8 points to 2113. Bitcoin added $3 to $258.

About this Archive

This page is an archive of entries from March 2015 listed from newest to oldest.

February 2015 is the previous archive.

April 2015 is the next archive.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12